Somatostatin content and release measured in cerebral biopsies from demented patients

https://doi.org/10.1016/0022-510X(87)90073-6Get rights and content

Abstract

Somatostatin-like immunoreactivity (SLIR) has been assayed in frontal and temporal cortex obtained at diagnostic craniotomy and post-mortem from patients with histologically verified Alzheimer's disease. SLIR content was not significantly different from controls in the frontal and temporal lobes, except in the temporal cortex post-mortem. The K+ -stimulated release of endogenous SLIR from tissue prisms (‘mini-slices’) prepared from neocortex obtained at diagnostic craniotomy from Alzheimer patients was not below the control values. Indices of cholinergic varicosities in similar samples from the frontal and temporal lobes are reduced; accordingly, somatostatin does not seem to be as prominently involved in these regions. Patients with Alzheimer's disease underwent neuropsychological assessment shortly before sampling the temporal lobe. Scores for WAIS full scale and the verbal subscale and the Token Test (measure of language comprehension) significantly correlated with the SLIR content; mean values (fmole/mg protein) were 817, 1468 and 1363 for aphasic and non-aphasic Alzheimer patients and controls, respectively. Ventricular fluid obtained from Alzheimer patients during surgery, did not have a significantly different SLIR content compared to controls. SLIR contents of ventricular fluid and neocortex from demented patients, without any specific histological changes in the sample obtained at diagnostic craniotomy, were also not significantly different from controls. Previously, we have shown that these demented patients, as well as those with histologically verified Alzheimer's disease, have a reduced SLIR content of lumbar fluid so it seems that somatostatin neurones located outside the frontal and temporal lobes are affected relatively early in the disease process.

References (48)

  • M.N. Rossor et al.

    Reduced amounts of immunoreactive somatostatin in temporal cortex in senile dementia of Alzheimer type

    Neurosci. Lett.

    (1980)
  • N.R. Sims et al.

    Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease

    Lancet

    (1980)
  • C.C.T. Smith et al.

    The evoked release of endogenous amino acids from tissue prisms of human neocortex

    Brain Res.

    (1983)
  • G.K. Wilcock et al.

    Plaques, tangles and dementia

    A quantitative study

    J. Neurol. Sci.

    (1982)
  • G.K. Wilcock et al.

    Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities

    J. Neurol. Sci.

    (1982)
  • P.L. Wood et al.

    Reduced lumbar CSF somatostatin levels in Alzheimer's disease

    Life Sci.

    (1982)
  • M.F. Beal et al.

    Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease

    Science

    (1985)
  • G.W. Bennett et al.

    Release of somatostatin from rat brain synaptosomes

    J. Neurochem.

    (1979)
  • D.M. Bowen et al.

    Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease

    Brit. Med. Bull.

    (1986)
  • D.M. Bowen et al.

    Accelerated aging or selective neuronal loss as an important cause of dementia

    Lancet

    (1979)
  • A. Brun

    An overview of light and electron microscopic changes

  • N.L. Foster et al.

    Alzheimer's disease: focal cortical changes shown by position emission tomography

    Neurology

    (1983)
  • P.T. Francis et al.

    Neurochemical studies in early-onset Alzheimer's disease: Possible influence and treatment

    N. Engl. J. Med.

    (1985)
  • S.H.C. Hendry et al.

    Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex

    J. Neurosci.

    (1984)
  • Cited by (54)

    • Retinal detachment neuropathology and potential strategies for neuroprotection

      2005, Survey of Ophthalmology
      Citation Excerpt :

      In contrast, the concentrations of glycine, GABA, aspartic acid (MHPG) and homovanillic acid (HVA), were all higher in the postmorten tissue. At the same time changes in concentration of 5–hydroxy–indoleacetic acid (5–HIAA) and the activity of choline acetyltransferase (ChAT) were not significant.21,54,64,66 Present evidence suggests that factors influencing the amount of neurochemicals and enzymes in postmortem tissue include age and sex.

    • Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: An immunohistochemical analysis

      2005, Neuroscience
      Citation Excerpt :

      The present study is the first comprehensive report demonstrating the distribution of SSTR1-5 in AD and nondemented (control) frontal cortex of human brain at the protein level. Consistent with previous studies, we observed a significant decrease in SST-immunopositive neurons in AD cortical tissue in comparison to control cortex (Arai et al., 1992; Francis et al., 1987; Gabriel et al., 1993). In addition, we found a significant decrease in NPY-immunoreactive neurons in AD cortex.

    View all citing articles on Scopus

    This was supported by the Brain Research Trust, the Medical Research Council and the Miriam Marks Charitable Trust.

    View full text